AdvaMed calls for ‘zero for zero’ medtech tariffs between US and UK

AdvaMed and its British counterpart called for urgent action to ensure the situation “does not devolve into a crisis.”

State attorneys general sue over ‘unconstitutional’ HHS restructuring

The lawsuit alleges the Trump administration overstepped its authority in reshaping the federal health department and asked the court to reinstate workers laid off last month.

US semiconductor import probe looms over medtech industry

Medical device manufacturers could face increased costs if the Commerce Department's Section 232 probe leads to tariffs on chips.

Philips cuts earnings forecast after calculating $340M tariff hit

CEO Roy Jakobs said tariff impacts require the company to accelerate localization of production in the U.S.

Zimmer Biomet expects $60M to $80M tariff impact this year

The orthopedics company lowered its earnings forecast, accounting for the tariffs and closing the acquisition of Paragon 28.

Cardinal Health cuts employees to offset up to $300M tariff charge

Executives said Thursday that the company has already laid off employees to help mitigate the effects of the Trump administration’s tariff policies.

Edwards gains expanded TAVR label for asymptomatic patients

The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement business with more patients becoming eligible for the treatment.

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

Intuitive secured a single port robot clearance, Resmed bought sleep testing facility Virtuox, and Precision Neuroscience hired an executive to support its BCI commercialization plans.

Stryker expects $200M tariff hit, lowers earnings forecast

CEO Kevin Lobo said that without the tariffs, the company would have “raised our earnings without question.”

GE Healthcare slashes 2025 profit forecast on tariff impact

The full-year tariff impact of 85 cents per share would have more than doubled without mitigation actions underway, executives said on the earnings call.

Abbott integrates diabetes data into Epic’s electronic health records

Linking the systems will allow clinicians to view glucose data captured by Libre glucose sensors within Epic’s systems.

HHS sued again over cuts to public health grants

In another lawsuit against the HHS over the grant cuts, municipalities in Texas, Tennessee, Ohio and Missouri, as well as a labor union, argue eliminating the funding would weaken their ability to respond to infectious disease outbreaks.

4 PFA studies in the spotlight at Heart Rhythm 2025

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm Society’s annual meeting.

Senators call for investigation into BCI privacy

In a letter to the FTC, three Democratic senators called for privacy standards for brain computer interface technology.

Updated April 30, 2025

Senseonics, Sequel partner to use 1-year CGM in automated insulin dosing system

The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device with Senseonics’ Eversense 365 CGM.